Using the mouse neuroblastoma cell line Neuro2A as a model system, we investigated whether siRNA-mediated reduction of Letm1 alone could recapitulate some of the novel mitochondrial phenotypes we have described here in LETM1-haploinsufficient WHS-patient LCLs. Here, LETM1 is linked to neuroblastoma.